Cyclic amino benzoic acid derivative

Details Cyclic amino benzoic acid derivative Cyclic amino benzoic acid derivative

2011-03-08

2011-03-08

Desai, Rita J (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S326000

Reexamination Certificate

active

07902367

ABSTRACT:
The present invention relates to cyclic amino benzoic acid derivatives which are effective in therapy of lipid metabolism abnormality, diabetes and the like as a human peroxisome proliferators-activated receptor (PPAR) agonist, in particular, as an agonist against human PPARα isoform, and addition salts thereof, and pharmaceutical compositions containing these compounds.A cyclic amino benzoic acid derivative represented by the general formula (1)[wherein a ring Ar represents an aryl group which may have substituent, or the like; Y represents a C1-C4alkylene, C2-C4alkenylene, C2-C4alkynylene, or the like; Z represents an oxygen atom, sulfur atom or —(CH2)n— (n represents 0, 1 or 2); X represents a hydrogen atom, halogen atom, lower alkyl group which may be substituted with a halogen atom, or the like; R represents a hydrogen atom or lower alkyl group, and —COOR substitutes for an ortho position or metha position of binding position of ring W] or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4010273 (1977-03-01), Bormann et al.
patent: 4064252 (1977-12-01), Murai et al.
patent: 4113871 (1978-09-01), Stach et al.
patent: 4237132 (1980-12-01), Murai et al.
patent: 5227490 (1993-07-01), Hartman et al.
patent: 5411972 (1995-05-01), Komoto et al.
patent: 5461066 (1995-10-01), Gericke et al.
patent: 5847005 (1998-12-01), Kasahara et al.
patent: 6028109 (2000-02-01), Willson
patent: 6166049 (2000-12-01), Smith
patent: 6204277 (2001-03-01), Shinkai et al.
patent: 6291459 (2001-09-01), Bhatnagar et al.
patent: 6294580 (2001-09-01), Willson et al.
patent: 6376503 (2002-04-01), Patane et al.
patent: 6506797 (2003-01-01), Nomura et al.
patent: 6518290 (2003-02-01), Sierra
patent: 6562828 (2003-05-01), Katoh et al.
patent: 6635655 (2003-10-01), Jayyosi et al.
patent: 6673817 (2004-01-01), Zhu et al.
patent: 6706763 (2004-03-01), Satoh et al.
patent: 6734199 (2004-05-01), Miyachi et al.
patent: 6884821 (2005-04-01), Shinoda et al.
patent: 7005440 (2006-02-01), Jayyosi et al.
patent: 2002/0019402 (2002-02-01), Dominguez et al.
patent: 2002/0028835 (2002-03-01), Hu et al.
patent: 2002/0032330 (2002-03-01), Nomura et al.
patent: 2002/0151545 (2002-10-01), Bisacchi et al.
patent: 2002/0165282 (2002-11-01), Hayward et al.
patent: 2002/0198195 (2002-12-01), Nazare et al.
patent: 2003/0032671 (2003-02-01), Urbahns et al.
patent: 2003/0040531 (2003-02-01), Fujishima et al.
patent: 2003/0134885 (2003-07-01), Bernardon et al.
patent: 2003/0144332 (2003-07-01), Glombik et al.
patent: 2003/0187068 (2003-10-01), Miyachi et al.
patent: 2004/0102500 (2004-05-01), Cano et al.
patent: 2004/0157885 (2004-08-01), Bagley et al.
patent: 2004/0198786 (2004-10-01), Gretzke et al.
patent: 2004/0204462 (2004-10-01), Goerlitzer et al.
patent: 2004/0209873 (2004-10-01), Stapper et al.
patent: 2004/0214888 (2004-10-01), Matsuura et al.
patent: 2005/0032899 (2005-02-01), Chen et al.
patent: 2005/0054582 (2005-03-01), Lehmann et al.
patent: 2005/0054671 (2005-03-01), Giannessi et al.
patent: 2005/0059669 (2005-03-01), Ajito et al.
patent: 2005/0096468 (2005-05-01), Van Emelen et al.
patent: 2005/0101521 (2005-05-01), Miyachi et al.
patent: 2005/0113362 (2005-05-01), Lindstedt et al.
patent: 2005/0165016 (2005-07-01), Van Emelen
patent: 2005/0228044 (2005-10-01), Shi et al.
patent: 2005/0228050 (2005-10-01), Orita et al.
patent: 2006/0089404 (2006-04-01), Desai et al.
patent: 2007/0154543 (2007-07-01), Hoshino et al.
patent: 2007/0191429 (2007-08-01), Bagley et al.
patent: 2007/0225296 (2007-09-01), Miyazaki et al.
patent: 2009/0036489 (2009-02-01), Nomura et al.
patent: 24 61 601 (1976-07-01), None
patent: 1 757 582 (2007-02-01), None
patent: 52-83676 (1977-07-01), None
patent: 63-91354 (1988-04-01), None
patent: 5-271072 (1993-10-01), None
patent: 6-72861 (1994-03-01), None
patent: 00/23407 (2000-04-01), None
patent: 00/64876 (2000-11-01), None
patent: 01/25181 (2001-04-01), None
patent: 01/27082 (2001-04-01), None
patent: 01/27090 (2001-04-01), None
patent: 02/44127 (2002-06-01), None
patent: 02/44130 (2002-06-01), None
patent: 02/46146 (2002-06-01), None
patent: 02/46161 (2002-06-01), None
patent: 02/098840 (2002-12-01), None
patent: 03/030889 (2003-04-01), None
patent: 03/043988 (2003-05-01), None
patent: 03/050077 (2003-06-01), None
patent: 03/051821 (2003-06-01), None
patent: 03/055867 (2003-07-01), None
patent: 03/059875 (2003-07-01), None
patent: 03/075929 (2003-09-01), None
patent: 03/076438 (2003-09-01), None
patent: 03/099766 (2003-12-01), None
patent: 2004/009533 (2004-01-01), None
patent: 2004/010936 (2004-02-01), None
patent: 2004/010992 (2004-02-01), None
patent: 2004/048334 (2004-06-01), None
patent: 2004/075815 (2004-09-01), None
patent: 2004/076402 (2004-09-01), None
patent: 2004/076447 (2004-09-01), None
patent: 2004/091600 (2004-10-01), None
patent: WO 2004/089918 (2004-10-01), None
patent: 2005/009942 (2005-02-01), None
patent: 2006/101108 (2006-09-01), None
Michael R. Wood et al., “A novel, one-step method for the conversion of primary alcohols into carbamate-protected amines”, Tetrahedron Letters, vol. 43, No. 21, pp. 3887-3890, 2002.
Supplementary European Search Report issued May 13, 2009 in European Application No. 05 77 0805.
P. Sarraf et al. “Differentiation and reversal of malignant changes in colon cancer through PPARγ”, Nature Medicine, vol. 4, No. 9, pp. 1046-1052 (Sep. 1998).
K. Schoonjans et al. “Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression”, Journal of Lipid Research, vol. 37, pp. 907-925 (1996).
P. Costet et al. “Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis”, Journal of Biological Chemistry, vol. 273, No. 45, pp. 29577-29585 (1998).
O. Braissant et al. “Differential Expression of Peroxisome Proliferator-Activated Receptors (PPARs): Tissue Distribution of PPAR-α, -β, and —γ in the Adult Rat”, Endocrinology, vol. 137, No. 1, pp. 354-366 (1996).
G. Picciola et al. “Composti Eterrociclici Contenenti IL Residuo Di Un Acido 4-Amminofenilalcanoico A Presunta Attivita Antiinfiammatoria”, Farmaco, Edizione Scientifica , 36(1), pp. 47-60 (1981), with English abstract.
B. Forman et al. “Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ”, Proc. Natl. Acad. Sci. USA, vol. 94, pp. 4312-4317 (Apr. 1997).
Y. Wang et al. “Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity”, Cell, vol. 113, pp. 159-170 (Apr. 18, 2003).
M. Göttlicher et al. “Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor”, Proc. Natl. Acad. Sci. USA, vol. 89, pp. 4653-4657 (May 1992).

Affiliated with

Also associated with

Rating

Cyclic amino benzoic acid derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclic amino benzoic acid derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic amino benzoic acid derivative will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2712157